-
1
-
-
84856536446
-
Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases
-
Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest 2012;122:440-7.
-
(2012)
J Clin Invest
, vol.122
, pp. 440-447
-
-
Kubo, A.1
Nagao, K.2
Amagai, M.3
-
2
-
-
78650274430
-
Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health
-
Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 2011;131:67-73.
-
(2011)
J Invest Dermatol
, vol.131
, pp. 67-73
-
-
Shaw, T.E.1
Currie, G.P.2
Koudelka, C.W.3
Simpson, E.L.4
-
3
-
-
0035725896
-
Trends in the prevalence of atopic dermatitis in school children: longitudinal study in Osaka Prefecture, Japan, from 1985 to 1997
-
Yura A, Shimizu T. Trends in the prevalence of atopic dermatitis in school children: longitudinal study in Osaka Prefecture, Japan, from 1985 to 1997. Br J Dermatol 2001;145:966-73.
-
(2001)
Br J Dermatol
, vol.145
, pp. 966-973
-
-
Yura, A.1
Shimizu, T.2
-
4
-
-
18844441676
-
Stable incidence of atopic dermatitis among children in Denmark during the 1990s
-
Olesen AB, Bang K, Juul S, Thestrup-Pedersen K. Stable incidence of atopic dermatitis among children in Denmark during the 1990s. Acta Derm Venereol 2005;85:244-7.
-
(2005)
Acta Derm Venereol
, vol.85
, pp. 244-247
-
-
Olesen, A.B.1
Bang, K.2
Juul, S.3
Thestrup-Pedersen, K.4
-
5
-
-
77957895641
-
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis
-
Elias PM. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Ann Dermatol 2010;22:245-54.
-
(2010)
Ann Dermatol
, vol.22
, pp. 245-254
-
-
Elias, P.M.1
-
6
-
-
84873333462
-
The multifunctional role of filaggrin in allergic skin disease
-
McAleer MA, Irvine AD. The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol 2013;131:280-91.
-
(2013)
J Allergy Clin Immunol
, vol.131
, pp. 280-291
-
-
McAleer, M.A.1
Irvine, A.D.2
-
8
-
-
33745586518
-
An update of the defensive barrier function of skin
-
Lee SH, Jeong SK, Ahn SK. An update of the defensive barrier function of skin. Yonsei Med J 2006;47:293-306.
-
(2006)
Yonsei Med J
, vol.47
, pp. 293-306
-
-
Lee, S.H.1
Jeong, S.K.2
Ahn, S.K.3
-
9
-
-
84886739838
-
Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin
-
Levin J, Friedlander SF, Del Rosso JQ. Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin. J Clin Aesthet Dermatol 2013;6:16-22.
-
(2013)
J Clin Aesthet Dermatol
, vol.6
, pp. 16-22
-
-
Levin, J.1
Friedlander, S.F.2
Del Rosso, J.Q.3
-
10
-
-
67649838095
-
Filaggrin in the frontline: role in skin barrier function and disease
-
Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009;122:1285-94.
-
(2009)
J Cell Sci
, vol.122
, pp. 1285-1294
-
-
Sandilands, A.1
Sutherland, C.2
Irvine, A.D.3
McLean, W.H.4
-
11
-
-
67449136333
-
Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis
-
Hatano Y, Man MQ, Uchida Y, Crumrine D, Scharschmidt TC, Kim EG, Mauro TM, Feingold KR, Elias PM, Holleran WM. Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis. J Invest Dermatol 2009;129:1824-35.
-
(2009)
J Invest Dermatol
, vol.129
, pp. 1824-1835
-
-
Hatano, Y.1
Man, M.Q.2
Uchida, Y.3
Crumrine, D.4
Scharschmidt, T.C.5
Kim, E.G.6
Mauro, T.M.7
Feingold, K.R.8
Elias, P.M.9
Holleran, W.M.10
-
12
-
-
46649119445
-
Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum
-
Kezic S, Kemperman PM, Koster ES, de Jongh CM, Thio HB, Campbell LE, Irvine AD, McLean WH, Puppels GJ, Caspers PJ. Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol 2008;128:2117-9.
-
(2008)
J Invest Dermatol
, vol.128
, pp. 2117-2119
-
-
Kezic, S.1
Kemperman, P.M.2
Koster, E.S.3
de Jongh, C.M.4
Thio, H.B.5
Campbell, L.E.6
Irvine, A.D.7
McLean, W.H.8
Puppels, G.J.9
Caspers, P.J.10
-
13
-
-
77957938941
-
Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis
-
Lee SE, Jeong SK, Lee SH. Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis. Yonsei Med J 2010;51:808-22.
-
(2010)
Yonsei Med J
, vol.51
, pp. 808-822
-
-
Lee, S.E.1
Jeong, S.K.2
Lee, S.H.3
-
14
-
-
84903477154
-
Severe skin inflammation and filaggrin mutation similarly alter skin barrier in atopic dermatitis patients
-
Forthcoming
-
Mócsai G, Gáspár K, Nagy G, Irinyi B, Kapitány A, Bíró T, Gyimesi E, Tóth B, Maródi L, Szegedi A. Severe skin inflammation and filaggrin mutation similarly alter skin barrier in atopic dermatitis patients. Br J Dermatol. Forthcoming 2013.
-
(2013)
Br J Dermatol
-
-
Mócsai, G.1
Gáspár, K.2
Nagy, G.3
Irinyi, B.4
Kapitány, A.5
Bíró, T.6
Gyimesi, E.7
Tóth, B.8
Maródi, L.9
Szegedi, A.10
-
16
-
-
84878656041
-
Ichthyosis vulgaris: the filaggrin mutation disease
-
Thyssen JP, Godoy-Gijon E, Elias PM. Ichthyosis vulgaris: the filaggrin mutation disease. Br J Dermatol 2013;168:1155-66.
-
(2013)
Br J Dermatol
, vol.168
, pp. 1155-1166
-
-
Thyssen, J.P.1
Godoy-Gijon, E.2
Elias, P.M.3
-
17
-
-
66749163178
-
A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming
-
Fallon PG, Sasaki T, Sandilands A, Campbell LE, Saunders SP, Mangan NE, Callanan JJ, Kawasaki H, Shiohama A, Kubo A, Sundberg JP, Presland RB, Fleckman P, Shimizu N, Kudoh J, Irvine AD, Amagai M, McLean WH. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009;41:602-8.
-
(2009)
Nat Genet
, vol.41
, pp. 602-608
-
-
Fallon, P.G.1
Sasaki, T.2
Sandilands, A.3
Campbell, L.E.4
Saunders, S.P.5
Mangan, N.E.6
Callanan, J.J.7
Kawasaki, H.8
Shiohama, A.9
Kubo, A.10
Sundberg, J.P.11
Presland, R.B.12
Fleckman, P.13
Shimizu, N.14
Kudoh, J.15
Irvine, A.D.16
Amagai, M.17
McLean, W.H.18
-
18
-
-
84861703829
-
Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice
-
1538-46.e6
-
Kawasaki H, Nagao K, Kubo A, Hata T, Shimizu A, Mizuno H, Yamada T, Amagai M. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. J Allergy Clin Immunol 2012;129:1538-46.e6.
-
(2012)
J Allergy Clin Immunol
, vol.129
-
-
Kawasaki, H.1
Nagao, K.2
Kubo, A.3
Hata, T.4
Shimizu, A.5
Mizuno, H.6
Yamada, T.7
Amagai, M.8
-
19
-
-
84887017487
-
Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects
-
Saunders SP, Goh CS, Brown SJ, Palmer CN, Porter RM, Cole C, Campbell LE, Gierlinski M, Barton GJ, Schneider G, Balmain A, Prescott AR, Weidinger S, Baurecht H, Kabesch M, Gieger C, Lee YA, Tavendale R, Mukhopadhyay S, Turner SW, Madhok VB, Sullivan FM, Relton C, Burn J, Meggitt S, Smith CH, Allen MA, Barker JN, Reynolds NJ, Cordell HJ, Irvine AD, McLean WH, Sandilands A, Fallon PG. Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects. J Allergy Clin Immunol 2013;132:1121-9.
-
(2013)
J Allergy Clin Immunol
, vol.132
, pp. 1121-1129
-
-
Saunders, S.P.1
Goh, C.S.2
Brown, S.J.3
Palmer, C.N.4
Porter, R.M.5
Cole, C.6
Campbell, L.E.7
Gierlinski, M.8
Barton, G.J.9
Schneider, G.10
Balmain, A.11
Prescott, A.R.12
Weidinger, S.13
Baurecht, H.14
Kabesch, M.15
Gieger, C.16
Lee, Y.A.17
Tavendale, R.18
Mukhopadhyay, S.19
Turner, S.W.20
Madhok, V.B.21
Sullivan, F.M.22
Relton, C.23
Burn, J.24
Meggitt, S.25
Smith, C.H.26
Allen, M.A.27
Barker, J.N.28
Reynolds, N.J.29
Cordell, H.J.30
Irvine, A.D.31
McLean, W.H.32
Sandilands, A.33
Fallon, P.G.34
more..
-
20
-
-
84887025956
-
A homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis
-
1111-20.e4
-
Sasaki T, Shiohama A, Kubo A, Kawasaki H, Ishida-Yamamoto A, Yamada T, Hachiya T, Shimizu A, Okano H, Kudoh J, Amagai M. A homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis. J Allergy Clin Immunol 2013;132:1111-20.e4.
-
(2013)
J Allergy Clin Immunol
, vol.132
-
-
Sasaki, T.1
Shiohama, A.2
Kubo, A.3
Kawasaki, H.4
Ishida-Yamamoto, A.5
Yamada, T.6
Hachiya, T.7
Shimizu, A.8
Okano, H.9
Kudoh, J.10
Amagai, M.11
-
21
-
-
79959249198
-
Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function
-
Gruber R, Elias PM, Crumrine D, Lin TK, Brandner JM, Hachem JP, Presland RB, Fleckman P, Janecke AR, Sandilands A, McLean WH, Fritsch PO, Mildner M, Tschachler E, Schmuth M. Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol 2011;178:2252-63.
-
(2011)
Am J Pathol
, vol.178
, pp. 2252-2263
-
-
Gruber, R.1
Elias, P.M.2
Crumrine, D.3
Lin, T.K.4
Brandner, J.M.5
Hachem, J.P.6
Presland, R.B.7
Fleckman, P.8
Janecke, A.R.9
Sandilands, A.10
McLean, W.H.11
Fritsch, P.O.12
Mildner, M.13
Tschachler, E.14
Schmuth, M.15
-
22
-
-
84887823825
-
IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication
-
Kim BE, Bin L, Ye YM, Ramamoorthy P, Leung DY. IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication. J Invest Dermatol 2013;133:2678-85.
-
(2013)
J Invest Dermatol
, vol.133
, pp. 2678-2685
-
-
Kim, B.E.1
Bin, L.2
Ye, Y.M.3
Ramamoorthy, P.4
Leung, D.Y.5
-
23
-
-
84873249337
-
Acute modulations in stratum corneum permeability barrier function affect claudin expression and epidermal tight junction function via changes of epidermal calcium gradient
-
Baek JH, Lee SE, Choi KJ, Choi EH, Lee SH. Acute modulations in stratum corneum permeability barrier function affect claudin expression and epidermal tight junction function via changes of epidermal calcium gradient. Yonsei Med J 2013;54:523-8.
-
(2013)
Yonsei Med J
, vol.54
, pp. 523-528
-
-
Baek, J.H.1
Lee, S.E.2
Choi, K.J.3
Choi, E.H.4
Lee, S.H.5
-
24
-
-
84875808184
-
Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice
-
Sugawara T, Iwamoto N, Akashi M, Kojima T, Hisatsune J, Sugai M, Furuse M. Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice. J Dermatol Sci 2013;70:12-8.
-
(2013)
J Dermatol Sci
, vol.70
, pp. 12-18
-
-
Sugawara, T.1
Iwamoto, N.2
Akashi, M.3
Kojima, T.4
Hisatsune, J.5
Sugai, M.6
Furuse, M.7
-
25
-
-
73949120263
-
External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers
-
Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 2009;206:2937-46.
-
(2009)
J Exp Med
, vol.206
, pp. 2937-2946
-
-
Kubo, A.1
Nagao, K.2
Yokouchi, M.3
Sasaki, H.4
Amagai, M.5
-
26
-
-
79952307688
-
Tight junction defects in patients with atopic dermatitis
-
773-86.e1-7
-
De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, Berger AE, Zhang K, Vidyasagar S, Yoshida T, Boguniewicz M, Hata T, Schneider LC, Hanifin JM, Gallo RL, Novak N, Weidinger S, Beaty TH, Leung DY, Barnes KC, Beck LA. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 2011;127:773-86.e1-7.
-
(2011)
J Allergy Clin Immunol
, vol.127
-
-
De Benedetto, A.1
Rafaels, N.M.2
McGirt, L.Y.3
Ivanov, A.I.4
Georas, S.N.5
Cheadle, C.6
Berger, A.E.7
Zhang, K.8
Vidyasagar, S.9
Yoshida, T.10
Boguniewicz, M.11
Hata, T.12
Schneider, L.C.13
Hanifin, J.M.14
Gallo, R.L.15
Novak, N.16
Weidinger, S.17
Beaty, T.H.18
Leung, D.Y.19
Barnes, K.C.20
Beck, L.A.21
more..
-
27
-
-
84873569974
-
Impaired tight junctions obstruct stratum corneum formation by altering polar lipid and profilaggrin processing
-
Yuki T, Komiya A, Kusaka A, Kuze T, Sugiyama Y, Inoue S. Impaired tight junctions obstruct stratum corneum formation by altering polar lipid and profilaggrin processing. J Dermatol Sci 2013;69:148-58.
-
(2013)
J Dermatol Sci
, vol.69
, pp. 148-158
-
-
Yuki, T.1
Komiya, A.2
Kusaka, A.3
Kuze, T.4
Sugiyama, Y.5
Inoue, S.6
-
28
-
-
84875220580
-
Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair
-
Kuo IH, Carpenter-Mendini A, Yoshida T, McGirt LY, Ivanov AI, Barnes KC, Gallo RL, Borkowski AW, Yamasaki K, Leung DY, Georas SN, De Benedetto A, Beck LA. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol 2013;133:988-98.
-
(2013)
J Invest Dermatol
, vol.133
, pp. 988-998
-
-
Kuo, I.H.1
Carpenter-Mendini, A.2
Yoshida, T.3
McGirt, L.Y.4
Ivanov, A.I.5
Barnes, K.C.6
Gallo, R.L.7
Borkowski, A.W.8
Yamasaki, K.9
Leung, D.Y.10
Georas, S.N.11
De Benedetto, A.12
Beck, L.A.13
-
29
-
-
0031744403
-
Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing
-
Mauro T, Holleran WM, Grayson S, Gao WN, Man MQ, Kriehuber E, Behne M, Feingold KR, Elias PM. Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch Dermatol Res 1998;290:215-22.
-
(1998)
Arch Dermatol Res
, vol.290
, pp. 215-222
-
-
Mauro, T.1
Holleran, W.M.2
Grayson, S.3
Gao, W.N.4
Man, M.Q.5
Kriehuber, E.6
Behne, M.7
Feingold, K.R.8
Elias, P.M.9
-
30
-
-
4344659169
-
Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus Aureus
-
Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus Aureus. Am J Clin Dermatol 2004;5:217-23.
-
(2004)
Am J Clin Dermatol
, vol.5
, pp. 217-223
-
-
Rippke, F.1
Schreiner, V.2
Doering, T.3
Maibach, H.I.4
-
31
-
-
11944270052
-
A proteolytic cascade of kallikreins in the stratum corneum
-
Brattsand M, Stefansson K, Lundh C, Haasum Y, Egelrud T. A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol 2005;124:198-203.
-
(2005)
J Invest Dermatol
, vol.124
, pp. 198-203
-
-
Brattsand, M.1
Stefansson, K.2
Lundh, C.3
Haasum, Y.4
Egelrud, T.5
-
32
-
-
33747339417
-
Serine protease signaling of epidermal permeability barrier homeostasis
-
Hachem JP, Houben E, Crumrine D, Man MQ, Schurer N, Roelandt T, Choi EH, Uchida Y, Brown BE, Feingold KR, Elias PM. Serine protease signaling of epidermal permeability barrier homeostasis. J Invest Dermatol 2006;126:2074-86.
-
(2006)
J Invest Dermatol
, vol.126
, pp. 2074-2086
-
-
Hachem, J.P.1
Houben, E.2
Crumrine, D.3
Man, M.Q.4
Schurer, N.5
Roelandt, T.6
Choi, E.H.7
Uchida, Y.8
Brown, B.E.9
Feingold, K.R.10
Elias, P.M.11
-
33
-
-
58849157836
-
Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease
-
Rattenholl A, Steinhoff M. Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease. Drug News Perspect 2008;21:369-81.
-
(2008)
Drug News Perspect
, vol.21
, pp. 369-381
-
-
Rattenholl, A.1
Steinhoff, M.2
-
34
-
-
0038720558
-
Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin
-
Steinhoff M, Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS, Luger TA, Schmelz M. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003;23:6176-80.
-
(2003)
J Neurosci
, vol.23
, pp. 6176-6180
-
-
Steinhoff, M.1
Neisius, U.2
Ikoma, A.3
Fartasch, M.4
Heyer, G.5
Skov, P.S.6
Luger, T.A.7
Schmelz, M.8
-
35
-
-
78149464736
-
Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model
-
Briot A, Lacroix M, Robin A, Steinhoff M, Deraison C, Hovnanian A. Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model. J Invest Dermatol 2010;130:2736-42.
-
(2010)
J Invest Dermatol
, vol.130
, pp. 2736-2742
-
-
Briot, A.1
Lacroix, M.2
Robin, A.3
Steinhoff, M.4
Deraison, C.5
Hovnanian, A.6
-
37
-
-
84856453019
-
Association of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China
-
Zhao LP, Di Z, Zhang L, Wang L, Ma L, Lv Y, Hong Y, Wei H, Chen HD, Gao XH. Association of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China. J Eur Acad Dermatol Venereol 2012;26:572-7.
-
(2012)
J Eur Acad Dermatol Venereol
, vol.26
, pp. 572-577
-
-
Zhao, L.P.1
Di, Z.2
Zhang, L.3
Wang, L.4
Ma, L.5
Lv, Y.6
Hong, Y.7
Wei, H.8
Chen, H.D.9
Gao, X.H.10
-
38
-
-
0038579516
-
Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population
-
Kato A, Fukai K, Oiso N, Hosomi N, Murakami T, Ishii M. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol 2003;148:665-9.
-
(2003)
Br J Dermatol
, vol.148
, pp. 665-669
-
-
Kato, A.1
Fukai, K.2
Oiso, N.3
Hosomi, N.4
Murakami, T.5
Ishii, M.6
-
39
-
-
34247238705
-
A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis
-
Vasilopoulos Y, Cork MJ, Teare D, Marinou I, Ward SJ, Duff GW, Tazi-Ahnini R. A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis. Allergy 2007;62:514-9.
-
(2007)
Allergy
, vol.62
, pp. 514-519
-
-
Vasilopoulos, Y.1
Cork, M.J.2
Teare, D.3
Marinou, I.4
Ward, S.J.5
Duff, G.W.6
Tazi-Ahnini, R.7
-
40
-
-
47349085166
-
Proteolytically active allergens cause barrier breakdown
-
Roelandt T, Heughebaert C, Hachem JP. Proteolytically active allergens cause barrier breakdown. J Invest Dermatol 2008;128:1878-80.
-
(2008)
J Invest Dermatol
, vol.128
, pp. 1878-1880
-
-
Roelandt, T.1
Heughebaert, C.2
Hachem, J.P.3
-
41
-
-
47349102541
-
Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery
-
Jeong SK, Kim HJ, Youm JK, Ahn SK, Choi EH, Sohn MH, Kim KE, Hong JH, Shin DM, Lee SH. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J Invest Dermatol 2008;128:1930-9.
-
(2008)
J Invest Dermatol
, vol.128
, pp. 1930-1939
-
-
Jeong, S.K.1
Kim, H.J.2
Youm, J.K.3
Ahn, S.K.4
Choi, E.H.5
Sohn, M.H.6
Kim, K.E.7
Hong, J.H.8
Shin, D.M.9
Lee, S.H.10
-
42
-
-
75549085674
-
Staphylococcus aureus extracellular protease causes epidermal barrier dysfunction
-
Hirasawa Y, Takai T, Nakamura T, Mitsuishi K, Gunawan H, Suto H, Ogawa T, Wang XL, Ikeda S, Okumura K, Ogawa H. Staphylococcus aureus extracellular protease causes epidermal barrier dysfunction. J Invest Dermatol 2010;130:614-7.
-
(2010)
J Invest Dermatol
, vol.130
, pp. 614-617
-
-
Hirasawa, Y.1
Takai, T.2
Nakamura, T.3
Mitsuishi, K.4
Gunawan, H.5
Suto, H.6
Ogawa, T.7
Wang, X.L.8
Ikeda, S.9
Okumura, K.10
Ogawa, H.11
-
43
-
-
80054026326
-
Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise
-
Sertznig P, Reichrath J. Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise. Dermatoendocrinol 2011;3:130-5.
-
(2011)
Dermatoendocrinol
, vol.3
, pp. 130-135
-
-
Sertznig, P.1
Reichrath, J.2
-
44
-
-
73149125138
-
Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators
-
160-9.e1-5
-
Hatano Y, Man MQ, Uchida Y, Crumrine D, Mauro TM, Feingold KR, Elias PM, Holleran WM. Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators. J Allergy Clin Immunol 2010;125:160-9.e1-5.
-
(2010)
J Allergy Clin Immunol
, vol.125
-
-
Hatano, Y.1
Man, M.Q.2
Uchida, Y.3
Crumrine, D.4
Mauro, T.M.5
Feingold, K.R.6
Elias, P.M.7
Holleran, W.M.8
-
45
-
-
33947615887
-
Peroxisome proliferator- activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms
-
Wohlfert EA, Nichols FC, Nevius E, Clark RB. Peroxisome proliferator- activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms. J Immunol 2007;178:4129-35.
-
(2007)
J Immunol
, vol.178
, pp. 4129-4135
-
-
Wohlfert, E.A.1
Nichols, F.C.2
Nevius, E.3
Clark, R.B.4
-
46
-
-
84882286067
-
Expressions of peroxisome proliferator-activated receptors (PPARs) are directly influenced by permeability barrier abrogation and inflammatory cytokines and depressed PPARalpha modulates expressions of chemokines and epidermal differentiation-related molecules in keratinocytes
-
Adachi Y, Hatano Y, Sakai T, Fujiwara S. Expressions of peroxisome proliferator-activated receptors (PPARs) are directly influenced by permeability barrier abrogation and inflammatory cytokines and depressed PPARalpha modulates expressions of chemokines and epidermal differentiation-related molecules in keratinocytes. Exp Dermatol 2013;22:606-8.
-
(2013)
Exp Dermatol
, vol.22
, pp. 606-608
-
-
Adachi, Y.1
Hatano, Y.2
Sakai, T.3
Fujiwara, S.4
-
47
-
-
41449115848
-
Peroxisome proliferator- activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis
-
962-8.e6
-
Staumont-Sallé D, Abboud G, Brénuchon C, Kanda A, Roumier T, Lavogiez C, Fleury S, Rémy P, Papin JP, Bertrand-Michel J, Tercé F, Staels B, Delaporte E, Capron M, Dombrowicz D. Peroxisome proliferator- activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis. J Allergy Clin Immunol 2008;121:962-8.e6.
-
(2008)
J Allergy Clin Immunol
, vol.121
-
-
Staumont-Sallé, D.1
Abboud, G.2
Brénuchon, C.3
Kanda, A.4
Roumier, T.5
Lavogiez, C.6
Fleury, S.7
Rémy, P.8
Papin, J.P.9
Bertrand-Michel, J.10
Tercé, F.11
Staels, B.12
Delaporte, E.13
Capron, M.14
Dombrowicz, D.15
-
48
-
-
80051798789
-
Efficacy of combined peroxisome proliferator-activated receptor-alpha ligand and glucocorticoid therapy in a murine model of atopic dermatitis
-
Hatano Y, Elias PM, Crumrine D, Feingold KR, Katagiri K, Fujiwara S. Efficacy of combined peroxisome proliferator-activated receptor-alpha ligand and glucocorticoid therapy in a murine model of atopic dermatitis. J Invest Dermatol 2011;131:1845-52.
-
(2011)
J Invest Dermatol
, vol.131
, pp. 1845-1852
-
-
Hatano, Y.1
Elias, P.M.2
Crumrine, D.3
Feingold, K.R.4
Katagiri, K.5
Fujiwara, S.6
-
49
-
-
49549092038
-
Systemic PPARgamma ligation inhibits allergic immune response in the skin
-
Dahten A, Koch C, Ernst D, Schnöller C, Hartmann S, Worm M. Systemic PPARgamma ligation inhibits allergic immune response in the skin. J Invest Dermatol 2008;128:2211-8.
-
(2008)
J Invest Dermatol
, vol.128
, pp. 2211-2218
-
-
Dahten, A.1
Koch, C.2
Ernst, D.3
Schnöller, C.4
Hartmann, S.5
Worm, M.6
-
50
-
-
38549161215
-
A retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of atopic dermatitis
-
Behshad R, Cooper KD, Korman NJ. A retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of atopic dermatitis. Arch Dermatol 2008;144:84-8.
-
(2008)
Arch Dermatol
, vol.144
, pp. 84-88
-
-
Behshad, R.1
Cooper, K.D.2
Korman, N.J.3
-
51
-
-
84885956811
-
Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model
-
Nakajima K, Terao M, Takaishi M, Kataoka S, Goto-Inoue N, Setou M, Horie K, Sakamoto F, Ito M, Azukizawa H, Kitaba S, Murota H, Itami S, Katayama I, Takeda J, Sano S. Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model. J Invest Dermatol 2013;133:2555-65.
-
(2013)
J Invest Dermatol
, vol.133
, pp. 2555-2565
-
-
Nakajima, K.1
Terao, M.2
Takaishi, M.3
Kataoka, S.4
Goto-Inoue, N.5
Setou, M.6
Horie, K.7
Sakamoto, F.8
Ito, M.9
Azukizawa, H.10
Kitaba, S.11
Murota, H.12
Itami, S.13
Katayama, I.14
Takeda, J.15
Sano, S.16
-
52
-
-
84896701729
-
Lipid abnormalities and lipid-based repair strategies in atopic dermatitis
-
with the editorial assistance of Joan Wakefield
-
Elias PM; with the editorial assistance of Joan Wakefield. Lipid abnormalities and lipid-based repair strategies in atopic dermatitis. Biochim Biophys Acta 2014;1841:323-30.
-
(2014)
Biochim Biophys Acta
, vol.1841
, pp. 323-330
-
-
Elias, P.M.1
-
53
-
-
84872692919
-
Innate immune defense system of the skin
-
32-8.e8-9
-
Afshar M, Gallo RL. Innate immune defense system of the skin. Vet Dermatol 2013;24:32-8.e8-9.
-
(2013)
Vet Dermatol
, vol.24
-
-
Afshar, M.1
Gallo, R.L.2
-
54
-
-
84862968750
-
Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37
-
Wang G, Epand RF, Mishra B, Lushnikova T, Thomas VC, Bayles KW, Epand RM. Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37. Antimicrob Agents Chemother 2012;56:845-56.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 845-856
-
-
Wang, G.1
Epand, R.F.2
Mishra, B.3
Lushnikova, T.4
Thomas, V.C.5
Bayles, K.W.6
Epand, R.M.7
-
55
-
-
61349169039
-
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense
-
Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 2009;30:131-41.
-
(2009)
Trends Immunol
, vol.30
, pp. 131-141
-
-
Lai, Y.1
Gallo, R.L.2
-
56
-
-
40649124294
-
Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers
-
Aberg KM, Man MQ, Gallo RL, Ganz T, Crumrine D, Brown BE, Choi EH, Kim DK, Schröder JM, Feingold KR, Elias PM. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol 2008;128:917-25.
-
(2008)
J Invest Dermatol
, vol.128
, pp. 917-925
-
-
Aberg, K.M.1
Man, M.Q.2
Gallo, R.L.3
Ganz, T.4
Crumrine, D.5
Brown, B.E.6
Choi, E.H.7
Kim, D.K.8
Schröder, J.M.9
Feingold, K.R.10
Elias, P.M.11
-
57
-
-
0037057645
-
Endogenous antimicrobial peptides and skin infections in atopic dermatitis
-
Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-60.
-
(2002)
N Engl J Med
, vol.347
, pp. 1151-1160
-
-
Ong, P.Y.1
Ohtake, T.2
Brandt, C.3
Strickland, I.4
Boguniewicz, M.5
Ganz, T.6
Gallo, R.L.7
Leung, D.Y.8
-
58
-
-
0041331649
-
Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes
-
Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003;171:3262-9.
-
(2003)
J Immunol
, vol.171
, pp. 3262-3269
-
-
Nomura, I.1
Goleva, E.2
Howell, M.D.3
Hamid, Q.A.4
Ong, P.Y.5
Hall, C.F.6
Darst, M.A.7
Gao, B.8
Boguniewicz, M.9
Travers, J.B.10
Leung, D.Y.11
-
59
-
-
33646482761
-
Cathelicidin deficiency predisposes to eczema herpeticum
-
Howell MD, Wollenberg A, Gallo RL, Flaig M, Streib JE, Wong C, Pavicic T, Boguniewicz M, Leung DY. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol 2006;117:836-41.
-
(2006)
J Allergy Clin Immunol
, vol.117
, pp. 836-841
-
-
Howell, M.D.1
Wollenberg, A.2
Gallo, R.L.3
Flaig, M.4
Streib, J.E.5
Wong, C.6
Pavicic, T.7
Boguniewicz, M.8
Leung, D.Y.9
-
60
-
-
84883599387
-
Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions
-
Kopfnagel V, Harder J, Werfel T. Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions. Curr Opin Allergy Clin Immunol 2013;13:531-6.
-
(2013)
Curr Opin Allergy Clin Immunol
, vol.13
, pp. 531-536
-
-
Kopfnagel, V.1
Harder, J.2
Werfel, T.3
-
61
-
-
33644831004
-
High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis
-
de Jongh GJ, Zeeuwen PL, Kucharekova M, Pfundt R, van der Valk PG, Blokx W, Dogan A, Hiemstra PS, van de Kerkhof PC, Schalkwijk J. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 2005;125:1163-73.
-
(2005)
J Invest Dermatol
, vol.125
, pp. 1163-1173
-
-
de Jongh, G.J.1
Zeeuwen, P.L.2
Kucharekova, M.3
Pfundt, R.4
van der Valk, P.G.5
Blokx, W.6
Dogan, A.7
Hiemstra, P.S.8
van de Kerkhof, P.C.9
Schalkwijk, J.10
-
62
-
-
77954824600
-
Expression of antimicrobial peptides such as LL-37 and hBD-2 in nonlesional skin of atopic individuals
-
Goo J, Ji JH, Jeon H, Kim MJ, Jeon SY, Cho MY, Lee SH, Choi EH. Expression of antimicrobial peptides such as LL-37 and hBD-2 in nonlesional skin of atopic individuals. Pediatr Dermatol 2010;27:341-8.
-
(2010)
Pediatr Dermatol
, vol.27
, pp. 341-348
-
-
Goo, J.1
Ji, J.H.2
Jeon, H.3
Kim, M.J.4
Jeon, S.Y.5
Cho, M.Y.6
Lee, S.H.7
Choi, E.H.8
-
63
-
-
67649958313
-
Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema
-
Ballardini N, Johansson C, Lilja G, Lindh M, Linde Y, Scheynius A, Agerberth B. Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema. Br J Dermatol 2009;161:40-7.
-
(2009)
Br J Dermatol
, vol.161
, pp. 40-47
-
-
Ballardini, N.1
Johansson, C.2
Lilja, G.3
Lindh, M.4
Linde, Y.5
Scheynius, A.6
Agerberth, B.7
-
64
-
-
49749104216
-
Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin
-
Gambichler T, Skrygan M, Tomi NS, Othlinghaus N, Brockmeyer NH, Altmeyer P, Kreuter A. Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol 2008;147:17-24.
-
(2008)
Int Arch Allergy Immunol
, vol.147
, pp. 17-24
-
-
Gambichler, T.1
Skrygan, M.2
Tomi, N.S.3
Othlinghaus, N.4
Brockmeyer, N.H.5
Altmeyer, P.6
Kreuter, A.7
-
65
-
-
78650277281
-
Urocanic acid in the skin: a mixed blessing?
-
Gibbs NK, Norval M. Urocanic acid in the skin: a mixed blessing? J Invest Dermatol 2011;131:14-7.
-
(2011)
J Invest Dermatol
, vol.131
, pp. 14-17
-
-
Gibbs, N.K.1
Norval, M.2
-
66
-
-
84903445861
-
Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with the use of GRADE and implications for practice and research
-
Forthcoming
-
Garritsen FM, Brouwer MW, Limpens J, Spuls PI. Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with the use of GRADE and implications for practice and research. Br J Dermatol. Forthcoming 2013.
-
(2013)
Br J Dermatol
-
-
Garritsen, F.M.1
Brouwer, M.W.2
Limpens, J.3
Spuls, P.I.4
-
67
-
-
42049083163
-
Gene expression of cytokines in atopic eczema before and after ultraviolet A1 phototherapy
-
Gambichler T, Kreuter A, Tomi NS, Othlinghaus N, Altmeyer P, Skrygan M. Gene expression of cytokines in atopic eczema before and after ultraviolet A1 phototherapy. Br J Dermatol 2008;158:1117-20.
-
(2008)
Br J Dermatol
, vol.158
, pp. 1117-1120
-
-
Gambichler, T.1
Kreuter, A.2
Tomi, N.S.3
Othlinghaus, N.4
Altmeyer, P.5
Skrygan, M.6
-
68
-
-
57349167517
-
Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement
-
Hong SP, Kim MJ, Jung MY, Jeon H, Goo J, Ahn SK, Lee SH, Elias PM, Choi EH. Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement. J Invest Dermatol 2008;128:2880-7.
-
(2008)
J Invest Dermatol
, vol.128
, pp. 2880-2887
-
-
Hong, S.P.1
Kim, M.J.2
Jung, M.Y.3
Jeon, H.4
Goo, J.5
Ahn, S.K.6
Lee, S.H.7
Elias, P.M.8
Choi, E.H.9
-
69
-
-
43749102455
-
Heliotherapy improves vitamin D balance and atopic dermatitis
-
Vähävihu K, Ylianttila L, Salmelin R, Lamberg-Allardt C, Viljakainen H, Tuohimaa P, Reunala T, Snellman E. Heliotherapy improves vitamin D balance and atopic dermatitis. Br J Dermatol 2008;158:1323-8.
-
(2008)
Br J Dermatol
, vol.158
, pp. 1323-1328
-
-
Vähävihu, K.1
Ylianttila, L.2
Salmelin, R.3
Lamberg-Allardt, C.4
Viljakainen, H.5
Tuohimaa, P.6
Reunala, T.7
Snellman, E.8
-
70
-
-
47949099916
-
From endoplasmic-reticulum stress to the inflammatory response
-
Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature 2008;454:455-62.
-
(2008)
Nature
, vol.454
, pp. 455-462
-
-
Zhang, K.1
Kaufman, R.J.2
-
71
-
-
80053204171
-
Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway
-
Park K, Elias PM, Oda Y, Mackenzie D, Mauro T, Holleran WM, Uchida Y. Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway. J Biol Chem 2011;286:34121-30.
-
(2011)
J Biol Chem
, vol.286
, pp. 34121-34130
-
-
Park, K.1
Elias, P.M.2
Oda, Y.3
Mackenzie, D.4
Mauro, T.5
Holleran, W.M.6
Uchida, Y.7
-
72
-
-
84882248309
-
Ultraviolet radiation regulates cortisol activity in a waveband-dependent manner in human skin ex vivo
-
Skobowiat C, Sayre RM, Dowdy JC, Slominski AT. Ultraviolet radiation regulates cortisol activity in a waveband-dependent manner in human skin ex vivo. Br J Dermatol 2013;168:595-601.
-
(2013)
Br J Dermatol
, vol.168
, pp. 595-601
-
-
Skobowiat, C.1
Sayre, R.M.2
Dowdy, J.C.3
Slominski, A.T.4
-
73
-
-
84864001201
-
DC-derived TSLP promotes Th2 polarization in LPS-primed allergic airway inflammation
-
Zhang Y, Zhou X, Zhou B. DC-derived TSLP promotes Th2 polarization in LPS-primed allergic airway inflammation. Eur J Immunol 2012;42:1735-43.
-
(2012)
Eur J Immunol
, vol.42
, pp. 1735-1743
-
-
Zhang, Y.1
Zhou, X.2
Zhou, B.3
-
74
-
-
33847134006
-
Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells
-
Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, Chartier S, Paquette N, Ziegler SF, Sarfati M, Delespesse G. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007;204:253-8.
-
(2007)
J Exp Med
, vol.204
, pp. 253-258
-
-
Allakhverdi, Z.1
Comeau, M.R.2
Jessup, H.K.3
Yoon, B.R.4
Brewer, A.5
Chartier, S.6
Paquette, N.7
Ziegler, S.F.8
Sarfati, M.9
Delespesse, G.10
-
75
-
-
33746792458
-
Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis
-
Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci U S A 2006;103:11736-41.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 11736-11741
-
-
Li, M.1
Hener, P.2
Zhang, Z.3
Kato, S.4
Metzger, D.5
Chambon, P.6
-
76
-
-
77950266156
-
Increased serum thymic stromal lymphopoietin in children with atopic dermatitis
-
Lee EB, Kim KW, Hong JY, Jee HM, Sohn MH, Kim KE. Increased serum thymic stromal lymphopoietin in children with atopic dermatitis. Pediatr Allergy Immunol 2010;21:e457-60.
-
(2010)
Pediatr Allergy Immunol
, vol.21
-
-
Lee, E.B.1
Kim, K.W.2
Hong, J.Y.3
Jee, H.M.4
Sohn, M.H.5
Kim, K.E.6
-
77
-
-
84859832022
-
Thymic stromal lymphopoietin (TSLP)-mediated dermal inflammation aggravates experimental asthma
-
Han H, Xu W, Headley MB, Jessup HK, Lee KS, Omori M, Comeau MR, Marshak-Rothstein A, Ziegler SF. Thymic stromal lymphopoietin (TSLP)-mediated dermal inflammation aggravates experimental asthma. Mucosal Immunol 2012;5:342-51.
-
(2012)
Mucosal Immunol
, vol.5
, pp. 342-351
-
-
Han, H.1
Xu, W.2
Headley, M.B.3
Jessup, H.K.4
Lee, K.S.5
Omori, M.6
Comeau, M.R.7
Marshak-Rothstein, A.8
Ziegler, S.F.9
-
78
-
-
70249093313
-
Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2
-
Kouzaki H, O'Grady SM, Lawrence CB, Kita H. Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol 2009;183:1427-34.
-
(2009)
J Immunol
, vol.183
, pp. 1427-1434
-
-
Kouzaki, H.1
O'Grady, S.M.2
Lawrence, C.B.3
Kita, H.4
-
79
-
-
84874541752
-
Protease activity enhances production of thymic stromal lymphopoietin and basophil accumulation in flaky tail mice
-
Moniaga CS, Jeong SK, Egawa G, Nakajima S, Hara-Chikuma M, Jeon JE, Lee SH, Hibino T, Miyachi Y, Kabashima K. Protease activity enhances production of thymic stromal lymphopoietin and basophil accumulation in flaky tail mice. Am J Pathol 2013;182:841-51.
-
(2013)
Am J Pathol
, vol.182
, pp. 841-851
-
-
Moniaga, C.S.1
Jeong, S.K.2
Egawa, G.3
Nakajima, S.4
Hara-Chikuma, M.5
Jeon, J.E.6
Lee, S.H.7
Hibino, T.8
Miyachi, Y.9
Kabashima, K.10
-
80
-
-
77952058742
-
Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract
-
Moniaga CS, Egawa G, Kawasaki H, Hara-Chikuma M, Honda T, Tanizaki H, Nakajima S, Otsuka A, Matsuoka H, Kubo A, Sakabe J, Tokura Y, Miyachi Y, Amagai M, Kabashima K. Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract. Am J Pathol 2010;176:2385-93.
-
(2010)
Am J Pathol
, vol.176
, pp. 2385-2393
-
-
Moniaga, C.S.1
Egawa, G.2
Kawasaki, H.3
Hara-Chikuma, M.4
Honda, T.5
Tanizaki, H.6
Nakajima, S.7
Otsuka, A.8
Matsuoka, H.9
Kubo, A.10
Sakabe, J.11
Tokura, Y.12
Miyachi, Y.13
Amagai, M.14
Kabashima, K.15
-
81
-
-
37049001821
-
Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges
-
Man MQ, Hatano Y, Lee SH, Man M, Chang S, Feingold KR, Leung DY, Holleran W, Uchida Y, Elias PM. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol 2008;128:79-86.
-
(2008)
J Invest Dermatol
, vol.128
, pp. 79-86
-
-
Man, M.Q.1
Hatano, Y.2
Lee, S.H.3
Man, M.4
Chang, S.5
Feingold, K.R.6
Leung, D.Y.7
Holleran, W.8
Uchida, Y.9
Elias, P.M.10
-
82
-
-
84860625144
-
The effect of adipose-derived stem cell-cultured media on oxazolone treated atopic dermatitis- like murine model
-
Lee HJ, Jung M, Kim JH, Yoon NY, Choi EH. The effect of adipose-derived stem cell-cultured media on oxazolone treated atopic dermatitis- like murine model. Ann Dermatol 2012;24:181-8.
-
(2012)
Ann Dermatol
, vol.24
, pp. 181-188
-
-
Lee, H.J.1
Jung, M.2
Kim, J.H.3
Yoon, N.Y.4
Choi, E.H.5
-
83
-
-
8044234352
-
Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice
-
Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997;9:461-6.
-
(1997)
Int Immunol
, vol.9
, pp. 461-466
-
-
Matsuda, H.1
Watanabe, N.2
Geba, G.P.3
Sperl, J.4
Tsudzuki, M.5
Hiroi, J.6
Matsumoto, M.7
Ushio, H.8
Saito, S.9
Askenase, P.W.10
Ra, C.11
-
84
-
-
0035126071
-
Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis
-
Aioi A, Tonogaito H, Suto H, Hamada K, Ra CR, Ogawa H, Maibach H, Matsuda H. Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis. Br J Dermatol 2001;144:12-8.
-
(2001)
Br J Dermatol
, vol.144
, pp. 12-18
-
-
Aioi, A.1
Tonogaito, H.2
Suto, H.3
Hamada, K.4
Ra, C.R.5
Ogawa, H.6
Maibach, H.7
Matsuda, H.8
-
85
-
-
0037083291
-
Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice
-
Yagi R, Nagai H, Iigo Y, Akimoto T, Arai T, Kubo M. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J Immunol 2002;168:2020-7.
-
(2002)
J Immunol
, vol.168
, pp. 2020-2027
-
-
Yagi, R.1
Nagai, H.2
Iigo, Y.3
Akimoto, T.4
Arai, T.5
Kubo, M.6
-
87
-
-
84858317268
-
The Role of TSLP in IL-13-induced atopic march
-
Zhu Z, Oh MH, Yu J, Liu YJ, Zheng T. The Role of TSLP in IL-13-induced atopic march. Sci Rep 2011;1:23.
-
(2011)
Sci Rep
, vol.1
, pp. 23
-
-
Zhu, Z.1
Oh, M.H.2
Yu, J.3
Liu, Y.J.4
Zheng, T.5
-
88
-
-
66249095960
-
Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma
-
Demehri S, Morimoto M, Holtzman MJ, Kopan R. Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. PLoS Biol 2009;7:e1000067.
-
(2009)
PLoS Biol
, vol.7
-
-
Demehri, S.1
Morimoto, M.2
Holtzman, M.J.3
Kopan, R.4
-
89
-
-
84856002592
-
Cutting edge: persistence of increased mast cell numbers in tissues links dermatitis to enhanced airway disease in a mouse model of atopy
-
Hershko AY, Charles N, Olivera A, Alvarez-Errico D, Rivera J. Cutting edge: persistence of increased mast cell numbers in tissues links dermatitis to enhanced airway disease in a mouse model of atopy. J Immunol 2012;188:531-5.
-
(2012)
J Immunol
, vol.188
, pp. 531-535
-
-
Hershko, A.Y.1
Charles, N.2
Olivera, A.3
Alvarez-Errico, D.4
Rivera, J.5
-
90
-
-
84874889571
-
Barrier-restoring therapies in atopic dermatitis: current approaches and future perspectives
-
Valdman-Grinshpoun Y, Ben-Amitai D, Zvulunov A. Barrier-restoring therapies in atopic dermatitis: current approaches and future perspectives. Dermatol Res Pract 2012;2012:923134.
-
(2012)
Dermatol Res Pract
, vol.2012
, pp. 923134
-
-
Valdman-Grinshpoun, Y.1
Ben-Amitai, D.2
Zvulunov, A.3
-
91
-
-
84872603337
-
Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function
-
Lin TK, Man MQ, Santiago JL, Park K, Roelandt T, Oda Y, Hupe M, Crumrine D, Lee HJ, Gschwandtner M, Thyssen JP, Trullas C, Tschachler E, Feingold KR, Elias PM. Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function. J Invest Dermatol 2013;133:469-78.
-
(2013)
J Invest Dermatol
, vol.133
, pp. 469-478
-
-
Lin, T.K.1
Man, M.Q.2
Santiago, J.L.3
Park, K.4
Roelandt, T.5
Oda, Y.6
Hupe, M.7
Crumrine, D.8
Lee, H.J.9
Gschwandtner, M.10
Thyssen, J.P.11
Trullas, C.12
Tschachler, E.13
Feingold, K.R.14
Elias, P.M.15
-
92
-
-
84865085421
-
Guidelines for treatment of atopic eczema (atopic dermatitis) part I
-
European Dermatology Forum (EDF); European Academy of Dermatology and Venereology (EADV); European Federation of Allergy (EFA); European Task Force on Atopic Dermatitis (ETFAD); European Society of Pediatric Dermatology (ESPD); Global Allergy and Asthma European Network (GA2LEN)
-
Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, Schäfer T, Schwennesen T, Seidenari S, Simon D, Ständer S, Stingl G, Szalai S, Szepietowski JC, Taïeb A, Werfel T, Wollenberg A, Darsow U; European Dermatology Forum (EDF); European Academy of Dermatology and Venereology (EADV); European Federation of Allergy (EFA); European Task Force on Atopic Dermatitis (ETFAD); European Society of Pediatric Dermatology (ESPD); Global Allergy and Asthma European Network (GA2LEN). Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 2012;26:1045-60.
-
(2012)
J Eur Acad Dermatol Venereol
, vol.26
, pp. 1045-1060
-
-
Ring, J.1
Alomar, A.2
Bieber, T.3
Deleuran, M.4
Fink-Wagner, A.5
Gelmetti, C.6
Gieler, U.7
Lipozencic, J.8
Luger, T.9
Oranje, A.P.10
Schäfer, T.11
Schwennesen, T.12
Seidenari, S.13
Simon, D.14
Ständer, S.15
Stingl, G.16
Szalai, S.17
Szepietowski, J.C.18
Taïeb, A.19
Werfel, T.20
Wollenberg, A.21
Darsow, U.22
more..
-
93
-
-
84886036219
-
Barrier-repair prescription moisturizers: do we really need them? Facts and controversies
-
Wolf R, Parish LC. Barrier-repair prescription moisturizers: do we really need them? Facts and controversies. Clin Dermatol 2013;31:787-91.
-
(2013)
Clin Dermatol
, vol.31
, pp. 787-791
-
-
Wolf, R.1
Parish, L.C.2
-
95
-
-
84855873391
-
Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids
-
Kircik LH, Del Rosso JQ. Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids. J Clin Aesthet Dermatol 2011;4:25-31.
-
(2011)
J Clin Aesthet Dermatol
, vol.4
, pp. 25-31
-
-
Kircik, L.H.1
Del Rosso, J.Q.2
-
96
-
-
74049086065
-
Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis
-
Sugarman JL, Parish LC. Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis. J Drugs Dermatol 2009;8:1106-11.
-
(2009)
J Drugs Dermatol
, vol.8
, pp. 1106-1111
-
-
Sugarman, J.L.1
Parish, L.C.2
-
97
-
-
79953180580
-
Pseudoceramide- containing physiological lipid mixture reduces adverse effects of topical steroids
-
Kim HJ, Park HJ, Yun JN, Jeong SK, Ahn SK, Lee SH. Pseudoceramide- containing physiological lipid mixture reduces adverse effects of topical steroids. Allergy Asthma Immunol Res 2011;3:96-102.
-
(2011)
Allergy Asthma Immunol Res
, vol.3
, pp. 96-102
-
-
Kim, H.J.1
Park, H.J.2
Yun, J.N.3
Jeong, S.K.4
Ahn, S.K.5
Lee, S.H.6
-
98
-
-
0141887511
-
The characterization of molecular organization of multilamellar emulsions containing pseudoceramide and type III synthetic ceramide
-
Park BD, Youm JK, Jeong SK, Choi EH, Ahn SK, Lee SH. The characterization of molecular organization of multilamellar emulsions containing pseudoceramide and type III synthetic ceramide. J Invest Dermatol 2003;121:794-801.
-
(2003)
J Invest Dermatol
, vol.121
, pp. 794-801
-
-
Park, B.D.1
Youm, J.K.2
Jeong, S.K.3
Choi, E.H.4
Ahn, S.K.5
Lee, S.H.6
-
99
-
-
84861194891
-
Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression
-
Grether-Beck S, Felsner I, Brenden H, Kohne Z, Majora M, Marini A, Jaenicke T, Rodriguez-Martin M, Trullas C, Hupe M, Elias PM, Krutmann J. Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression. J Invest Dermatol 2012;132:1561-72.
-
(2012)
J Invest Dermatol
, vol.132
, pp. 1561-1572
-
-
Grether-Beck, S.1
Felsner, I.2
Brenden, H.3
Kohne, Z.4
Majora, M.5
Marini, A.6
Jaenicke, T.7
Rodriguez-Martin, M.8
Trullas, C.9
Hupe, M.10
Elias, P.M.11
Krutmann, J.12
-
100
-
-
84870615198
-
Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model
-
Gschwandtner M, Mildner M, Mlitz V, Gruber F, Eckhart L, Werfel T, Gutzmer R, Elias PM, Tschachler E. Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model. Allergy 2013;68:37-47.
-
(2013)
Allergy
, vol.68
, pp. 37-47
-
-
Gschwandtner, M.1
Mildner, M.2
Mlitz, V.3
Gruber, F.4
Eckhart, L.5
Werfel, T.6
Gutzmer, R.7
Elias, P.M.8
Tschachler, E.9
|